MAPPING AND LINKING BETWEEN THE EQ-5D-5L AND THE PROPR IN THE UNITED STATES

被引：0
|
作者：
Tang, X. [1 ]
Hays, R. [2 ]
Cella, D. [3 ]
Acaster, S. [4 ]
Sikora, Kessler A. [5 ]
Vera, Llonch M. [6 ]
Hanmer, J. [7 ]
机构：
[1] Northwestern Univ, Chicago, IL USA
[2] UCLA, Los Angeles, CA USA
[3] Northwestern Univ, Evanston, IL USA
[4] Acaster Lloyd Consulting, London, England
[5] Ionis Pharmaceut, San Antonio, TX USA
[6] Ionis Pharmaceut, Boston, MA USA
[7] Univ Pittsburgh, Pittsburgh, PA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCR49
引用
收藏
页码：S305 / S305
页数：1
相关论文
共 50 条
  • [41] Comparing EQ-5D-5L, Propr, Sf-6D and TTO Utilities in Patients With Chronic Skin Diseases
    Szabo, A.
    Brodszky, V
    Rencz, F.
    VALUE IN HEALTH, 2022, 25 (12) : S497 - S497
  • [42] EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom.
    Alava, Monica Hernandez
    Wailoo, Allan
    Grimm, Sabine
    Pudney, Stephen
    Gomes, Manuel
    Sadique, Zia
    Meads, David
    O'Dwyer, John
    Barton, Garry
    Irvine, Lisa
    VALUE IN HEALTH, 2018, 21 (01) : 49 - 56
  • [43] Mapping the Haem-A-QoL to the EQ-5D-5L in patients with hemophilia
    Xu, Richard Huan
    Dong, Dong
    Luo, Nan
    Wong, Eliza Lai-Yi
    Yang, Renchi
    Liu, Junshuai
    Yuan, Huiqin
    Zhang, Shuyang
    QUALITY OF LIFE RESEARCH, 2022, 31 (05) : 1533 - 1544
  • [44] Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study
    Al Sayah, Fatima
    Bansback, Nick
    Bryan, Stirling
    Ohinmaa, Arto
    Poissant, Lise
    Pullenayegum, Eleanor
    Xie, Feng
    Johnson, Jeffrey A.
    QUALITY OF LIFE RESEARCH, 2016, 25 (07) : 1679 - 1685
  • [45] Normative profile of the EQ-5D-5L dimensions, EQ-5D-5L index and EQ-VAS scores for the general Thai population
    Krittaphas Kangwanrattanakul
    Quality of Life Research, 2023, 32 : 2489 - 2502
  • [46] Determinants of time trade-off valuations for EQ-5D-5L health states: data from the Canadian EQ-5D-5L valuation study
    Fatima Al Sayah
    Nick Bansback
    Stirling Bryan
    Arto Ohinmaa
    Lise Poissant
    Eleanor Pullenayegum
    Feng Xie
    Jeffrey A. Johnson
    Quality of Life Research, 2016, 25 : 1679 - 1685
  • [47] VALIDITY OF THE EQ-5D-3L AND EQ-5D-5L IN ADVANCED MELANOMA
    Franken, M.
    van Dongen, A.
    Leeneman, B.
    Groot, Uyl-De C. A.
    Aarts, M. J. B.
    van den Berkmortel, F. W. P. J.
    Blank, C. U.
    Boers-Sonderen, M. J.
    van den Eertwegh, A. J. M.
    de Groot, J. W. B.
    Haanen, J. B. A. G.
    Hospers, G. A. P.
    Kapiteijn, E.
    de Meza, M. M.
    Piersma, D.
    van Rijn, R. S.
    Boer, Stevense-den M. A. M.
    Suijkerbuijk, K. P. M.
    van der Veldt, A. A. M.
    Vreugdenhil, G.
    Wouters, M. W. J. M.
    Blommestein, H. M.
    Versteegh, M.
    VALUE IN HEALTH, 2022, 25 (01) : S244 - S244
  • [48] Normative profile of the EQ-5D-5L dimensions, EQ-5D-5L index and EQ-VAS scores for the general Thai population
    Kangwanrattanakul, Krittaphas
    QUALITY OF LIFE RESEARCH, 2023, 32 (09) : 2489 - 2502
  • [49] Comparing EQ-5D-5L, PROPr, SF-6D and TTO utilities in patients with chronic skin diseases
    Szabo, Akos
    Brodszky, Valentin
    Rencz, Fanni
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2024,
  • [50] EQ-5D-3L and EQ-5D-5L population norms for Thailand
    Kangwanrattanakul, Krittaphas
    Krageloh, Christian U.
    BMC PUBLIC HEALTH, 2024, 24 (01)
12345